Related Experiment Video
Updated: Oct 2, 2026

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?
Reiner Buchhorn1, Martin Hulpke-Wette, Wolfgang Ruschewski
1Department of Pediatric Cardiology and Cardiothoracic Surgery, Georg-August-University Göttingen, Germany. rbuchho@gwdg.de
Insights
Congenital heart failure in children downregulates beta-receptors, impacting recovery after heart surgery. Therapy, including propranolol, influences this beta-receptor gene expression and postoperative outcomes.
Area of Science:
- Pediatric Cardiology
- Molecular Biology
- Cardiothoracic Surgery
Background:
- Congenital heart disease (CHD) in children often involves neurohormonal activation.
- This activation can lead to downregulation of myocardial beta-receptors.
- Such changes may significantly affect the postoperative course following cardiothoracic surgery.
Purpose of the Study:
- To investigate the relationship between myocardial beta-receptor gene expression and postoperative outcomes in pediatric patients with CHD.
- To assess the impact of heart failure therapy on beta-receptor levels.
Main Methods:
- Myocardial biopsies were collected from 26 infants and children undergoing cardiac surgery.
- Patients were grouped based on intensive care unit (ICU) stay duration (less than 7 days vs. more than 7 days, including early deaths).
- Real-time polymerase chain reaction (PCR) was used to quantify beta1- and beta2-mRNA levels.
Main Results:
- Children with shorter ICU stays (Group 1) showed significantly higher myocardial beta1- and beta2-receptor gene expression compared to those with longer ICU stays (Group 2).
- Beta-receptor gene expression was lower in children receiving standard heart failure treatment versus those receiving additional propranolol.
- These findings suggest a correlation between receptor expression and clinical outcomes.
Conclusions:
- Downregulation of myocardial beta-receptors in pediatric congestive heart failure impacts postoperative recovery.
- The degree of beta-receptor downregulation is influenced by the severity of heart failure and the type of therapy administered.
- Targeting beta-receptor pathways may be crucial for improving outcomes in these patients.
Background:
Neurohormonal activation in children with heart failure due to congenital heart disease leads to downregulation of myocardial beta-receptors that may influence the postoperative course after cardiothoracic surgery.
Methods:
Myocardial biopsies of 26 children (aged 14+/-4 months) were obtained from the right atrium during cardiac surgery. Patients were allocated to either of two groups based on the duration of their intensive care unit stay: group 1 comprised those who stayed less than 7 days (n = 17), whereas group 2 comprised those who stayed more than 7 days, plus 3 infants who died during the early postoperative course (n = 9). For beta1- and beta2-mRNA quantitation, real-time polymerase chain reaction with fluorescence-labeled products was used.
Results:
Values for myocardial beta1-receptor gene expression were twice as high in group 1 children compared with group 2 (beta1-receptor 0.12+/-0.07 versus 0.06+/-0.03, p = 0.0016; beta2-receptor 0.12+/-0.07 versus 0.06+/-0.03, p = 0.0071). Beta-receptor gene expression in 16 children who received standard treatment for heart failure averaged lower than in the 10 children who received additional propranolol.
Conclusions:
Beta-receptor downregulation due to congestive heart failure has an impact on the postoperative course in children with congenital disease and depends on heart failure therapy.
Related Concept Videos
Mitral Stenosis III: Medical Management
Dysbiosis of the Gut Microbiota